Cue biopharma to host business update call and webcast

Boston, march 15, 2023 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific t cells directly within the patient's body, announced today that it will host a conference call and webcast to provide a business and clinical update on tuesday, march 21, 2023 at 4:30 p.m. edt. live and archived versions of the event can be accessed via the company's website.
CUE Ratings Summary
CUE Quant Ranking